1074-62-0

Usage

Uses

Used in Pharmaceutical Industry:
4-(Aminomethyl)cyclohexanemethanol is used as a pharmaceutical intermediate for the synthesis of various medications, including muscle relaxants and antispasmodics. Its unique properties contribute to the treatment of conditions such as chronic pain, muscle spasms, and neuralgia, providing relief and managing symptoms effectively.
Used in Polymer and Resin Production:
In the chemical industry, 4-(Aminomethyl)cyclohexanemethanol is utilized in the production of certain types of polymers and resins. Its chemical structure and reactivity make it suitable for creating materials with specific properties, such as durability and flexibility, for various applications.

InChI:InChI=1/C8H17NO/c9-5-7-1-3-8(6-10)4-2-7/h7-8,10H,1-6,9H2

Upstream product

• 100-49-2 cyclohexylmethyl alcohol 
• 105-08-8 bis-1,4-(hydroxymethyl)cyclohexane 
• 1197-17-7 4-aminomethyl-cyclohexanecarboxylic acid 

Downstream Products

• 840-84-6 {4-[(2-Chloro-benzylamino)-methyl]-cyclohexyl}-methanol 
• 1018674-46-8 trans-(4-Hydroxymethyl-cyclohexylmethyl)-carbamic acid tert-butyl ester 
• 916210-80-5 trans-4-(N-tert-butoxycarbonylaminomethyl)cyclohexane carboxaldehyde 
• 1018811-88-5 cyclopentyl (2S)-({[4-(aminomethyl)cyclohexyl]methyl}amino)(cyclohexyl)acetate 
• 1018811-87-4 cyclopentyl (2S)-{[(4-{[(tert-butoxycarbonyl)amino]methyl}cyclohexyl)methyl]amino}(cyclohexyl)acetate 
• 1018811-89-6 cyclopentyl (2S)-cyclohexyl{[(4-{[(3-{(1E)-3-[(1-isobutoxyethoxy)amino]-3-oxoprop-1-en-1-yl}benzyl)amino]methyl}cyclohexyl)methyl]amino}acetate 
• 7006-45-3 N-Benzyl-1-benzyloxymethyl-4-cyclohexanemethylamine 
• 729-51-1 (2-Chloro-benzyl)-(4-chloromethyl-cyclohexylmethyl)-amine 
• 726-54-5 4-Benzylaminomethylcyclohexylmethylchlorid 

Relevant academic research and scientific papers

Steric effects in the catalytic amination of γ-, δ-, and ε-glycols

The amination of butane-1,4-diol, isomeric dipropylene glycols, and cyclohexane-1,4-diyldimethanol in the presence of nickel/copper/chromium catalysts has been studied. The effect of the initial glycol structure on the reaction selectivity has been estima

PROCESS FOR PREPARING DI-, TRI- AND POLYAMINES BY HOMOGENEOUSLY CATALYZED ALCOHOL AMINATION

Process for preparing primary amines which have at least one functional group of the formula (—CH2—NH2) and at least one further primary amino group by alcohol amination of starting materials having at least one functional group of the formula (—CH2—OH) and at least one further functional group (—X), where (—X) is selected from among hydroxyl groups and primary amino groups, by means of ammonia with elimination of water, wherein the reaction is carried out homogeneously catalyzed in the presence of at least one complex catalyst comprising at least one element selected from groups 8, 9 and 10 of the Periodic Table and also at least one donor ligand.

CYCLOHEXANEDIMETHANAMINE BY DIRECT AMINATION OF CYCLOHEXANEDIMETHANOL

Embodiments of the present invention include methods for producing a cyclohexanedimethanamine by a reductive amination process.

HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE

Compounds of formula (I), and salts, N-oxides, hydrates and solvates thereof are histone deacetylase inhibitors and are useful in the treatment of cell proliferative diseases, including cancers: wherein Q, V and W independently represent -N= or -C=; B is

HDAC INHIBITORS

Compounds of formula (I) inhibit HDAC activity, wherein A, B and D independently represent =C- or =N-; W is a divalent radical -CH=CH- or CH2CH2-; R1 is a carboxylic acid group (-COOH), or an ester group which is hydrolysable by one or more intracellular carboxyesterase enzymes to a carboxylic acid group; R2 is the side chain of a natural or non-natural alpha amino acid; z is 0 or 1; and Y, L1, and X1 are as defined in the claims.